METABOLISMO ÓSEO, VASCULAR, ENFERMEDADES INFLAMATORIAS CRÓNICAS Y BIOMARCADORES
METOSEO
Instituto de Parasitología y Biomedicina López Neyra
Armilla, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Parasitología y Biomedicina López Neyra (8)
2024
-
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study
The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383
2017
-
A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294
2014
-
Analysis of ancestral and functionally relevant CD variants in systemic lupus erythematosus patients
PLoS ONE, Vol. 9, Núm. 11
2009
-
No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus
Lupus, Vol. 18, Núm. 3, pp. 230-234
-
STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk
Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753
2008
-
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus
Nature Genetics, Vol. 40, Núm. 2, pp. 211-216
-
Influence of mutations of proteinase activated receptors F2R/PAR1 and F2RL1/PAR2 on inflammatory bowel disease
Medicina Clinica, Vol. 131, Núm. 16, pp. 609-611
2007
-
Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus
Arthritis and Rheumatism, Vol. 56, Núm. 4, pp. 1234-1241